Get notified when PDSB files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsPDS Biotech files resale prospectus for up to 13.3M shares held by YA II PN, LTD; company gets no proceeds
Filed July 21, 2026 · ~1 min read
Key Changes
-
high
The prospectus covers resale of up to 13,315,823 shares by selling stockholder YA II PN, LTD, not a primary offering by PDS Biotech.
The Offering verify on EDGAR → -
high
Shares come from a warrant to buy 2,158,274 shares at $1.1824 each and conversion of a $6M promissory note into up to 11,157,549 shares.
The Offering verify on EDGAR → -
high
PDS Biotech will not receive proceeds from resale; it only gets cash if the warrant is exercised for cash.
The Offering verify on EDGAR →
This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (IMMR 10-Q) is open in full — no account needed.
Partner
Trade PDSB commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Sep 1, 2026 · How we verify